staurosporine aglycone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strietz, J | 1 |
| Stepputtis, SS | 1 |
| Preca, BT | 1 |
| Vannier, C | 1 |
| Kim, MM | 1 |
| Castro, DJ | 1 |
| Au, Q | 1 |
| Boerries, M | 1 |
| Busch, H | 1 |
| Aza-Blanc, P | 1 |
| Heynen-Genel, S | 1 |
| Bronsert, P | 1 |
| Kuster, B | 1 |
| Stickeler, E | 1 |
| Brabletz, T | 1 |
| Oshima, RG | 1 |
| Maurer, J | 1 |
1 other study available for staurosporine aglycone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer.
Topics: Animals; Antineoplastic Agents; Carbazoles; Caseins; Cell Differentiation; Cell Line, Tumor; Cell Pr | 2016 |